Pediatric Gaucher Disease Type 3 Presenting with Oculomotor Apraxia: A Case Report
- PMID: 39201895
- PMCID: PMC11352849
- DOI: 10.3390/children11080960
Pediatric Gaucher Disease Type 3 Presenting with Oculomotor Apraxia: A Case Report
Abstract
We report on a 4-year-old boy affected by Gaucher disease (GD) type 3, who presented with splenomegaly and a history of oculomotor apraxia. GD is a rare lysosomal storage disorder caused by glucocerebrosidase deficiency with multi-organ involvement. Besides common clinical features such as hepatosplenomegaly and skeletal involvement, less frequent neurological symptoms, such as oculomotor apraxia, are indicative of neuronopathic forms of the disease, namely GD type 3, to be confirmed both by enzyme activity and genetic testing. Overall, GD management requires a multidisciplinary approach involving metabolic pediatricians, neurologists, psychologists, and geneticists, and currently relies on early enzyme replacement therapy. Although enzyme replacement therapy has proved to be effective in improving systemic signs and symptoms, it is unable to alleviate neurological complications once these have occurred, as it does not pass across the blood-brain barrier. Neurological improvements may occur through indirect mechanisms. Thus, our case report aims to highlight the importance of considering GD in the differential diagnosis of pediatric patients presenting with splenomegaly associated with neurological manifestations, as early intervention may significantly modify the disease progression and prevent further irreversible complications.
Keywords: beta-glucocerebrosidase; enzyme replacement therapy; inherited metabolic diseases; lysosomal storage disorder; splenomegaly.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report.J Med Case Rep. 2017 Jan 20;11(1):19. doi: 10.1186/s13256-016-1147-5. J Med Case Rep. 2017. PMID: 28103924 Free PMC article.
-
Case report: Multidisciplinary collaboration in diagnosis and treatment of child gaucher disease.Front Pediatr. 2023 Mar 30;11:1057574. doi: 10.3389/fped.2023.1057574. eCollection 2023. Front Pediatr. 2023. PMID: 37063666 Free PMC article.
-
Obstacles to Early Diagnosis of Gaucher Disease.Ther Clin Risk Manag. 2025 Jan 25;21:93-101. doi: 10.2147/TCRM.S388266. eCollection 2025. Ther Clin Risk Manag. 2025. PMID: 39882275 Free PMC article. Review.
-
Pediatric Gaucher disease with intermediate type 2-3 phenotype associated with parkinsonian features and levodopa responsiveness.Parkinsonism Relat Disord. 2021 Oct;91:19-22. doi: 10.1016/j.parkreldis.2021.08.010. Epub 2021 Aug 19. Parkinsonism Relat Disord. 2021. PMID: 34454394
-
Gaucher disease: a diagnostic challenge for internists.Eur J Intern Med. 2014 Feb;25(2):117-24. doi: 10.1016/j.ejim.2013.09.006. Epub 2013 Oct 1. Eur J Intern Med. 2014. PMID: 24090739 Review.
Cited by
-
Diagnosis and genetic analysis of Gaucher disease in a pediatric case: a case report.Front Pediatr. 2025 Jul 28;13:1628525. doi: 10.3389/fped.2025.1628525. eCollection 2025. Front Pediatr. 2025. PMID: 40791806 Free PMC article.
References
-
- Weinreb N.J., Goker-Alpan O., Kishnani P.S., Longo N., Burrow T.A., Bernat J.A., Gupta P., Henderson N., Pedro H., Prada C.E., et al. The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here? Mol. Genet. Metab. 2022;136:4–21. doi: 10.1016/j.ymgme.2022.03.001. - DOI - PubMed
-
- Stirnemann J., Belmatoug N., Camou F., Serratrice C., Froissart R., Caillaud C., Levade T., Astudillo L., Serratrice J., Brassier A., et al. A review of Gaucher disease pathophysiology, clinical presentation and treatments. Int. J. Mol. Sci. 2017;18:441. doi: 10.3390/ijms18020441. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources